The FDA has proposed removing oral phenylephrine from its guidelines for over-the-counter drugs due to inefficacy as a decongestant. Use of this ingredient in cold and allergy medicines grew after a federal law required that pseudoephedrine-containing products be kept behind pharmacy counters.
The post FDA Takes Step Toward Removal of Ineffective Decongestants From the Market appeared first on MedCity News.
